This has been a very solid partnership. Dr. Chan has brought a unique competence to this collaboration along with a desire to create something meaningful for NASA’s space missions. For decades, the Holy Grail of portable biomedical diagnostics research has been the creation of a device that could measure dozens or hundreds of biomarkers from a tiny bit of biosample, such as a drop of blood. In my view, the rHEALTH and nanostrip technologies not only have the greatest potential to finally achieve this objective—with Chan’s know-how and dedication, they are likely to actually reach this goal.
Dr. Emily Nelson, NASA Glenn Research Center
